Sign in
4

Changes in Ownership

LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-19-004890

Options or other derivatives

  • EVP, R&D acquired 228,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TYLE PRAVEEN · EVP, R&D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-02-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +148,200 $5.16 2029-02-07 148,200 148,200 D
2019-02-07 Grant or award : show line 2 in the form Restricted Stock Units +79,800 79,800 79,800 D
Loading xslF345X03/form4.xml…